​

Xeris Biopharma (XERS) Revenue & Revenue Breakdown

OverviewForecastOwnershipFinancialsChartTranscripts

Xeris Biopharma Revenue Highlights

Latest Revenue (Y)

$163.91M

Latest Revenue (Q)

$52.86M

Main Segment (Y)

Product

Xeris Biopharma Revenue by Period

Xeris Biopharma Revenue by Year

DateRevenueChange
2023-12-31$163.91M48.68%
2022-12-31$110.25M-
2021-12-31$110.25M122.32%
2020-12-31$49.59M146.04%
2019-12-31$20.16M717.65%
2018-12-31$2.46M58.42%
2017-12-31$1.56M44.74%
2016-12-31$1.07M-

Xeris Biopharma generated $163.91M in revenue during NA 2024, up 48.68% compared to the previous quarter, and up 6649.66% compared to the same period a year ago.

Xeris Biopharma Revenue by Quarter

DateRevenueChange
2024-09-30$52.86M9.98%
2024-06-30$48.06M18.28%
2024-03-31$40.64M-8.45%
2023-12-31$44.39M-8.13%
2023-09-30$48.32M27.13%
2023-06-30$38.01M14.50%
2023-03-31$33.20M-12.66%
2022-12-31$38.01M27.87%
2022-09-30$29.73M17.46%
2022-06-30$25.31M14.65%
2022-03-31$22.07M3.01%
2021-12-31$21.43M94.19%
2021-09-30$11.04M23.91%
2021-06-30$8.91M10.62%
2021-03-31$8.05M13.57%
2020-12-31$7.09M-24.97%
2020-09-30$9.45M366.11%
2020-06-30$2.03M13.37%
2020-03-31$1.79M-4.08%
2019-12-31$1.86M477.09%
2019-09-30$323.00K0.94%
2019-06-30$320.00K29.03%
2019-03-31$248.00K-69.04%
2018-12-31$801.00K37.63%
2018-09-30$582.00K-28.94%
2018-06-30$819.00K211.41%
2018-03-31$263.00K-43.68%
2017-12-31$467.00K174.71%
2017-09-30$170.00K-69.91%
2017-06-30$565.00K59.60%
2017-03-31$354.00K-

Xeris Biopharma generated $52.86M in revenue during Q1 2025, up 9.98% compared to the previous quarter, and up 139.08% compared to the same period a year ago.

Xeris Biopharma Revenue Breakdown

Xeris Biopharma Revenue Breakdown by Product

Annual Revenue by Product

Product/ServiceDec 23Dec 22
Product$153.36M$109.26M
Keveyis$56.77M$49.31M

Xeris Biopharma's latest annual revenue breakdown by segment (product or service), as of Dec 23: Product (72.98%), and Keveyis (27.02%).

Quarterly Revenue by Product

Product/ServiceSep 24Mar 24Dec 23Sep 23Jun 23Mar 23Dec 22Sep 22Jun 22
Keveyis$12.19M$13.09M$40.91M$15.87M$14.09M$12.76M$13.80M$13.37M$12.81M
Product$52.86M$40.26M$111.67M$41.70M$36.89M$32.27M$32.54M$29.55M$25.26M

Xeris Biopharma's latest quarterly revenue breakdown by segment (product or service), as of Sep 24: Product (81.26%), and Keveyis (18.74%).

Xeris Biopharma Peer Comparison by Revenue

TickerCompanyLast Year RevenueLast Quarter Revenue
XERSXeris Biopharma$163.91M$52.86M
MCRBSeres Therapeutics$126.33M-
CDTXCidara Therapeutics$63.91M-
HOOKHOOKIPA Pharma$20.13M-
MREOMereo BioPharma Group$10.00M-
IBRXImmunityBio$622.00K$1.05M
XFORX4 Pharmaceuticals-$560.00K
PDSBPDS Bio--
DAWNDay One Biopharmaceuticals-$20.07M
INZYInozyme Pharma--
ELEVElevation Oncology--
TERNTerns Pharmaceuticals--
HEPAHepion Pharmaceuticals--

XERS Revenue FAQ

What is Xeris Biopharma’s yearly revenue?

Xeris Biopharma's yearly revenue for 2024 was $163.91M, representing an increase of 48.68% compared to 2023. The company's yearly revenue for 2023 was $110.25M, representing an increase of 0% compared to 2022. XERS's yearly revenue for 2022 was $110.25M, representing an increase of 122.32% compared to 2021.

What is Xeris Biopharma’s quarterly revenue?

Xeris Biopharma's quarterly revenue for Q1 2025 was $52.86M, a 9.98% increase from the previous quarter (Q4 2024), and a 9.40% increase year-over-year (Q1 2024). The company's quarterly revenue for Q4 2024 was $48.06M, a 18.28% increase from the previous quarter (Q3 2024), and a 26.46% increase year-over-year (Q4 2023). XERS's quarterly revenue for Q3 2024 was $40.64M, a -8.45% decrease from the previous quarter (Q2 2024), and a 22.42% increase year-over-year (Q3 2023).

What is Xeris Biopharma’s revenue growth rate?

Xeris Biopharma's revenue growth rate for the last 3 years (2022-2024) was 48.68%, and for the last 5 years (2020-2024) was 713.27%.

What are Xeris Biopharma’s revenue streams?

Xeris Biopharma's revenue streams in c 23 are Product, and Keveyis. Product generated $153.36M in revenue, accounting 72.98% of the company's total revenue, up 40.36% year-over-year. Keveyis generated $56.77M in revenue, accounting 27.02% of the company's total revenue, up 15.14% year-over-year.

What is Xeris Biopharma’s main source of revenue?

For the fiscal year ending Dec 23, the largest source of revenue of Xeris Biopharma was Product. This segment made a revenue of $153.36M, representing 72.98% of the company's total revenue.